Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Study of Saroglitazar Magnesium for PBC Patients with Incomplete Response or Intolerant to UDCA Therapy
NCT07424677Phase 3Recruiting
- Sponsor
- Zydus Therapeutics
- Start
- Aug 2026
- Primary completion
- Jul 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of saroglitazar in primary biliary cholangitis (PBC), sponsored by Zydus Therapeutics. Started Aug 2026; status: recruiting.
02
Drugs
saroglitazar
03
Conditions
primary biliary cholangitis (PBC)
Beyond the preview
Go deeper on NCT07424677.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07424677.